Imiquimod 5% cream in the treatment of multiple superficial basal cell carcinoma

被引：0
|
作者：
Freeman, M
Siller, G
Edwards, S
Amies, M
机构：
[1] Skin Ctr, Benowa, Qld, Australia
[2] Princess Alexandra Hosp, GARU, Dermatol OPD, Woolloongabba, Qld 4102, Australia
[3] Bealey Clin, Christchurch, New Zealand
[4] 3M Pharmaceut, Sydney, NSW, Australia
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.10.033
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P27
引用
收藏
页码：P7 / P7
页数：1
相关论文
共 50 条
  • [11] Cost-effectiveness analysis:: Aldaratm (imiquimod) cream, 5% in the treatment of superficial basal cell carcinoma in Norway
    Sverre, JM
    Kristensen, FKO
    Hamel-Gariépy, L
    Albrektsen, T
    VALUE IN HEALTH, 2005, 8 (06) : A143 - A143
  • [12] The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient
    Kagy, MK
    Amonette, R
    DERMATOLOGIC SURGERY, 2000, 26 (06) : 577 - 578
  • [13] Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas
    Marks, R
    Owens, M
    Walters, SA
    ARCHIVES OF DERMATOLOGY, 2004, 140 (10) : 1284 - 1285
  • [14] Reply re: "Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma"
    de Macedo, Erick M. S.
    Carneiro, Rachel C.
    Matayoshi, Suzana
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 27 (04): : 305 - 306
  • [15] Cost-effectiveness of treatment of superficial basal cell carcinoma:: surgical excision vs. imiquimod 5% cream
    Vanaclocha, F.
    Dauden, E.
    Badia, X.
    Guillen, C.
    Conejo-Mir, J. S.
    de Los Terreros, M. Sainz
    Hamel, L.
    Llorens, M. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (04) : 769 - 771
  • [16] Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas
    Paolino, Giovanni
    Didona, Dario
    Scarno, Marco
    Tallarico, Mariagrazia
    Cantoresi, Franca
    Calvieri, Stefano
    Mercuri, Santo Raffaele
    Piccolo, Domenico
    Bottoni, Ugo
    Kyriakou, Aikaterini
    Cantisani, Carmen
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [17] Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream
    Ezughah, Francesca I.
    Affleck, Andrew G.
    Evans, Alan
    Ibbotson, Sally H.
    Fleming, Colin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (03) : 156 - 158
  • [18] Imiquimod - In superficial basal cell carcinoma
    Oldfield, V
    Keating, GM
    Perry, CM
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2005, 6 (03) : 195 - 200
  • [19] Sclerotic basal cell carcinoma treated with imiquimod 5% cream
    Pace, N
    Brown, J
    Chapman, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P149 - P149
  • [20] Cost-effectiveness model of aldaratm (imiquimod) cream, 5% in superficial basal cell carcinoma in the Netherlands
    De Cock, E
    Nuijten, MJ
    Hollestein, A
    Hamel-Gariépy, L
    VALUE IN HEALTH, 2005, 8 (06) : A144 - A144
12345